Showing results (201-210 of 1,297) with videos related to

Sort By:
Pageof 130
BMC Health Services Research|June 18, 2021
Do remote dialysis services really cost more? An economic analysis of hospital and dialysis modality costs associated with dialysis services in urban, rural and remote settingsGillian Gorham, Kirsten Howard, Joan Cunningham, et al.
BMC Health Services Research|February 6, 2008
Study Protocol--Improving Access to Kidney Transplants (IMPAKT): a detailed account of a qualitative study investigating barriers to transplant for Australian Indigenous people with end-stage kidney diseaseJeannie Devitt, Alan Cass, Joan Cunningham, et al.
BMC Nephrology|October 13, 2017
Difficult conversations: Australian Indigenous patients' views on kidney transplantationJeannie Devitt, Kate Anderson, Joan Cunningham, et al.
Heart, Lung & Circulation|September 14, 2015
Long-term Outcomes of Patients with Acute Myocardial Infarction Presenting to Regional and Remote HospitalsSradha Kotwal, Isuru Ranasinghe, David Brieger, et al.
Heart, Lung & Circulation|November 6, 2022
Oral Anticoagulant Use in Patients With Atrial Fibrillation and Chronic Kidney Disease: A Review of the Evidence With Recommendations for Australian Clinical PracticeChristopher Hammett, Sunil V Badve, Peter G Kerr, et al.
Endocrinology, Diabetes & Metabolism|July 19, 2021
Canagliflozin, serum magnesium and cardiovascular outcomes-Analysis from the CANVAS ProgramKatherine M Wang, JingWei Li, Vivek Bhalla, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 12, 2021
Rationale, design, demographics and baseline characteristics of the randomized, controlled, Phase 2b SAPPHIRE study of verinurad plus allopurinol in patients with chronic kidney disease and hyperuricaemiaHiddo J L Heerspink, Austin G Stack, Robert Terkeltaub, et al.
Cardiovascular Diabetology|September 23, 2022
Initiation of the SGLT2 inhibitor canagliflozin to prevent kidney and heart failure outcomes guided by HbA1c, albuminuria, and predicted risk of kidney failureSok Cin Tye, Niels Jongs, Steven G Coca, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 8, 2025
Systemic Inflammation and the Risks of Adverse Kidney Outcomes in Adults With Atherosclerotic Cardiovascular DiseaseFaizan Mazhar, Edouard L Fu, Anne-Laure Faucon, et al.
Kidney International|November 26, 2016
Management of patients with diabetes and CKD: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies ConferenceVlado Perkovic, Rajiv Agarwal, Paola Fioretto, et al.
Pageof 130